Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
to study antibiotic tolerance in Mycobacterium abscessus, one of the most challenging to treat bacterial pathogens. The position is part of a newly funded international consortium that brings together
-
postdoctoral researcher in molecular microbiology to investigate the genetic basis of drug tolerance in Mycobacterium abscessus, one of the most challenging to treat bacterial pathogens. The position is part of
-
biology. This project builds on a key experimental barrier that we have overcome, enabling the rapid generation of high-impact structural data on bacterial secretion systems. Where to apply Website https
-
Link at the University of Tübingen invites applications for a PhD position. The project aims to systematically identify bacterial genes that control immune evasion in ESKAPE pathogens. Using CRISPR
-
. NPs and their (semi-)synthetic derivatives are the most prominent sources of novel drug leads. While the discovery of novel antibiotics has stagnated, only few of the NPs encoded in bacterial genomes
-
The Morley lab seeks an ambitious and motivated post-doctoral fellow to drive a research project addressing their choice of several open questions regarding pulmonary immunity against bacterial
-
Regulation of bacterial adherence to human cells by ZDHHC5-mediated S-acylation of cell surface proteins. School of Biosciences PhD Research Project Self Funded Dr M Collins, Dr Luke Green
-
serving as a resource to colleagues, reporting to the Sr. Bioprocess Development Manager. This role is pivotal in the microbial characterization of symbiotic commensal bacterial strains for manufacturing as
-
: an interdisciplinary approach to understanding the interaction between bacterial pathogens of environmental and zoonotic origin and the host’s innate immune system. ” In this thesis, we will develop structured partial
-
) that investigates the basic principles of microbial interactions with their hosts. Research topics include the study of viral and bacterial pathogens to better understand disease outcomes and improve therapies